**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 302-17-0 |Chloral hydrate | 98.5 | 206-117-5 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 25 36/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic if swallowed. Irritating to eyes and skin.Hygroscopic (absorbs
moisture from the air).Air sensitive.Light sensitive.
Potential Health Effects
Eye:
Causes severe eye irritation and possible injury.
Skin:
Causes skin irritation and possible burns.
Ingestion:
Harmful if swallowed. Symptoms may include: headache, excitement,
fatigue, nausea, vomiting, stupor, and coma. May cause central
nervous system depression.
Inhalation:
Inhalation of high concentrations may cause central nervous system
effects characterized by nausea, headache, dizziness, unconsciousness
and coma. Causes irritation of mucous membrane. Causes respiratory
tract irritation with possible burns.
Chronic:
Chronic inhalation may cause effects similar to those of acute
inhalation. Can be addictive. Effects may be delayed. Laboratory
experiments have resulted in mutagenic effects. Experimental
carcinogen.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Effects may be delayed. Ingestion of large quantities of this
material can depress the central nervous system. Stimulants may be
useful in certain situations; however, a professional decision is
required. Carefully evaluate respiratory status, provide an
intravenous line, oxygen and a cardiac monitor. The use of activated
charcoal is recommended over syrup of ipecac for treatment of
ingestion.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid generating dusty conditions. Provide ventilation.
Place under an inert atmosphere. Do not get water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Keep container tightly
closed. Do not get on skin or in eyes. Do not ingest or inhale.
Store protected from light. Handle under an inert atmosphere. Store
protected from air. Wash clothing before reuse. Keep from contact
with moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture. Store protected from light. Store under an
inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 302-17-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: Transparent, Colorless Crystals
Odor: Slightly acrid
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 97 deg C @ 760.00mmHg
Freezing/Melting Point: 57 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >97 deg C
Solubility in water: Freely Soluble.
Specific Gravity/Density: 1.9100g/cm3
Molecular Formula: C2H3Cl3O2
Molecular Weight: 165.40
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Air sensitive. Moisture sensitive. Sensitive to light.
Conditions to Avoid:
Light, dust generation, exposure to air, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Alkalis, alkaline earth metals, alkali carbonates, soluble
barbiturates, borax, tannin, iodides, permanganates, alcohols,
strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 302-17-0: FM8750000
LD50/LC50:
CAS# 302-17-0: Oral, mouse: LD50 = 1100 mg/kg; Oral, rat: LD50 = 479
mg/kg; Skin, rat: LD50 = 3030 mg/kg.
Oral, human: TDLo = 300 mg/kg (Central nervous system effects,
Cardiovascular effects).; Oral, woman: TDLo = 465 mg/kg (Eye
effects, Blood pressure
Carcinogenicity:
Chloral hydrate -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: II
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: II
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 25 Toxic if swallowed.
R 36/38 Irritating to eyes and skin.
Safety Phrases:
S 25 Avoid contact with eyes.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 302-17-0: 3
Canada
CAS# 302-17-0 is listed on Canada's DSL List.
CAS# 302-17-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 302-17-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 12/19/1998 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
3-Bromo-4-methylaniline, 97%
| 7745-91-7 |
|
2-Amino-3,5-Diiodobenzoic Acid, 98%
| 609-86-9 |
|
3-Chloro-2-methylpropene tech., 90%
| 563-47-3 |
|
4-Cyclohexylacetophenone, 98%
| 18594-05-3 |
|
2,4,6-Trihydroxybenzaldehyde, 97%
| 487-70-7 |
|
2-Dodecanone, 95%
| 6175-49-1 |
|
1-(4-Cyanophenyl)-piperazine hydrochloride
| 0-01-1 |
|
9-BBN crystalline dimer, 98%
| 21205-91-4 |
|
2,3-Pyridinedicarboxylic Anhydride,97%
| 699-98-9 |
|
N-tert-Butoxycarbonyl-L-Prolinol
| 69610-40-8 |
|
Toluene, P.A.
| 108-88-3 |
|
Tri-N-Butyl Phosphate
| 126-73-8 |
|
Tributylamine, P.A
| 102-82-9 |
|
Chloral hydrate, 98.5%
| 302-17-0 |
|
N-tert-Butoxycarbonyl-D-Prolinol
| 83435-58-9 |
|
3,5-Dimethyl-1-phenylpyrazole, 97%
| 1131-16-4 |
|
(4S)-4-Bromomethyl-2-Phenyl-1,3-Dioxane, 95%
| 201743-52-4 |
|
1,3,5-Trimethylpyrazole, 99%
| 1072-91-9 |
|
Trichloroethylene, reagent ACS, stabilized with 0.5% ethanol
| 64-17-5 |
|
Triethylene glycol, 99%
| 112-27-6 |
|
Triethylenetetramine, 95%
| 112-24-3 |
|
Hexyl Acetate, 99%
| 142-92-7 |
|
3,5-Diacetoxyacetophenone, 98+%
| 35086-59-0 |
|
2,4,5-Trihydroxybenzaldehyde
| 35094-87-2 |
|
Tetrahydroxy-1,4-quinone hydrate
| 123334-16-7 |
|
Trifluoroacetic acid, biochemical grade
| 76-05-1 |
|
Trifluoroacetic anhydride, 99+%
| 407-25-0 |
|
tert-Butanol-d10, 98%
| 53001-22-2 |
|
3-Methyl-2,4-pentanedione, mixture of tautomers, tech. 85%
| 815-57-6 |
|
1-(4-Methylphenyl)-2-methylpiperazine, 1:1 mixture of conformers, 97%
| 35947-11-6 |
|
Tris-(Hydroxymethyl)-Aminomethane, P.A.; Biochemical grade
| 77-86-1 |
|
Sodium phosphate, tribasic dodecahydrate, reagent ACS, powder
| 7601-54-9 |
|
Tungsten(vi) oxide 99+%
| 1314-35-8 |
|
Fluoranthene, 93%
| 206-44-0 |
|
4-Chloro-3-nitrobenzoyl chloride, 98%
| 38818-50-7 |
|
TMIO, 98%
| 0-01-1 |
|
4-Amino-2-chloro-6,7-dimethoxyquinazoline, 97%
| 23680-84-4 |
|
5-Chloro-3-pyridinol, 99%
| 74115-12-1 |
|
2-Chloro-5-chloromethylpyridine, tech. 90%
| 70258-18-3 |
|
7-Acetoxy-4-methylcoumarin, 98%
| 2747-05-9 |
|
3-Amino-2,5-dichlorobenzoic acid, 97%
| 133-90-4 |
|
6,11-Dihydrodibenzo[b,e]Thiepin-11-one, 97%
| 1531-77-7 |
|
Methylcyclopentane, 95%
| 96-37-7 |
|
3-Methylfuran, 98%
| 930-27-8 |
|
2-Amino-6-chloro-4-methoxypyrimidine, 98%
| 5734-64-5 |
|
Urea, 98%, Pearls
| 57-13-6 |
|
Vanillin, 99%
| 121-33-5 |
|
Vinyl acetate monomer, stabilized
| 108-05-4 |
|
N-Methylmaleimide
| 930-88-1 |
|
2-Acetyl-1-tetralone
| 17216-08-9 |
|
|